TECHNOLOGY · The Wall Street Journal

Silicon Valley Promises AI Will Cure Disease. Drugmaker CEOs Aren't Buying It.

Published: 2026-11-04T02:00:00.000Z · 3-Minute Executive Summary

The Wall Street Journal reports that no drug designed by artificial intelligence has won FDA clearance, and pharma leaders say biology is the obstacle.